JP MORGAN/PUT/TEVA PHARMACEUTICAL INDUSTRIES/10/1/17.01.25 Share Price

Warrant

DE000JB2FWT6

Market Closed - Börse Stuttgart 15:56:24 19/06/2024 BST
0.11 EUR 0.00% Intraday chart for JP MORGAN/PUT/TEVA PHARMACEUTICAL INDUSTRIES/10/1/17.01.25
Current month-15.38%
1 month-31.25%
Date Price Change
19/06/24 0.11 0.00%
18/06/24 0.11 -8.33%
17/06/24 0.12 +20.00%
14/06/24 0.1 -9.09%
13/06/24 0.11 0.00%

Delayed Quote Börse Stuttgart

Last update June 19, 2024 at 03:56 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer J.P. Morgan
WKN JB2FWT
ISINDE000JB2FWT6
Date issued 13/09/2023
Strike 10 $
Maturity 17/01/2025 (212 Days)
Parity 1 : 1
Emission price 1.41
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.45
Lowest since issue 0.1
Delta-0.13x
Omega 1.848
Premium48.22x
Gearing14.26x
Moneyness 0.5879
Difference Strike -7.01 $
Difference Strike %-70.10%
Spread 2
Spread %94.79%
Theoretical value 1.110
Implied Volatility 97.78 %
Total Loss Probability 64.93 %
Intrinsic value 0.000000
Present value 1.110
Break even 8.808 €
Theta-0.04x
Vega0.03x
Rho-0.02x

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
17.01 USD
Average target price
18.34 USD
Spread / Average Target
+7.80%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW